Neuronal Regulation of HSV Lytic and Latent Infection

HSV 溶解和潜伏感染的神经调节

• 批准号: 7573394
• 负责人: Nancy M. Sawtell
• 金额: $ 22.5万
• 依托单位: CINCINNATI CHILDRENS HOSP MED CTR
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-12-24 至 2010-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7573394
• 关键词: Acute; Address; Afferent Neurons; Antiviral Agents; Apoptosis; Arts; Biochemical; Biological; Blindness; Brain; Cells; Cessation of life; Cultured Cells; Data; Defense Mechanisms; Development; Disease; Encephalitis; Environment; Event; Evolution; Explosion; Family; Fibroblasts; Ganglia; Gene Transfer; Genome Stability; Goals; HIV; Health; Human; Immediate-Early Proteins; In Vitro; Individual; Infection; Inflammatory; Interferons; Knockout Mice; Knowledge; Lead; Life; Lytic; Lytic Phase; Lytic Virus; Maintenance; Malignant Neoplasms; Mediating; Methods; Molecular; Morbidity - disease rate; Mus; Myxoid cyst; Nervous system structure; Neurons; Nuclear; Oncolytic viruses; Outcome; Output; PML gene; Pathogenesis; Pathology; Physiological; Play; Population; Positioning Attribute; Prema; Probability; Proteins; Publishing; RNA Interference; Regulation; Regulatory Pathway; Repression; Research; Role; Sensory Ganglia; Series; Simplexvirus; TRIM Family; Testing; Time; Transgenic Animals; Tumor Suppression; Vaccine Design; Vaccines; Viral; Viral Genes; Viral Genome; Viral Proteins; Viral Vector; Virus; Virus Diseases; Virus Latency; Virus-Cell Membrane Interaction; Work; base; cell suicide; design; gene repression; gene transfer vector; genital herpes; improved; in vivo; in vivo Model; inhibitor/antagonist; innovation; knowledge base; latent infection; member; mortality; mouse model; mutant; neonate; novel; novel therapeutics; pathogen; premature; prevent; programs; public health relevance; reactivation from latency; research study; response; stressor; transcription factor PML; transmission process; treatment strategy; virus pathogenesis

DESCRIPTION (provided by applicant): Herpes simplex virus infection is the leading cause of sporadic fatal encephalitis worldwide and infectious blindness in the US. Transmission to the neonate is associated with high morbidity and mortality and an individual with genital HSV infection is 2-3 times more likely to acquire HIV. Once infected, there is currently no way to eliminate the latent viral genome, which persists for the life of the host and periodically reactivates producing infectious viral progeny that then is transmitted to new hosts. Considering that more than 70% of the world's population is currently infected with HSV, the direct and indirect impact of this virus to human health is profound. Despite this importance, our understanding of the viral/host interactions underlying the core aspects HSV pathogenesis in vivo, namely the establishment of and reactivation from latency, remains inadequate to direct the rationale design of preventative and treatment strategies. The long term goal of the proposed research is to understand those interactions between HSV and the nervous system which result in the establishment of latency and subsequent reactivation and the long term associated pathologies. Progress has been made in identifying key viral genes involved regulating latency, but the physiological changes in neurons that subvert or enhance the entry into and exit from latency are not understood. In this proposal we will pursue our important new observations that promyelocytic leukemia protein (PML) and the formation of PML-nuclear bodies (PML-NB) in neurons in vivo plays a central role in the establishment of latency and reactivation. Using state of the art quantitative in vivo methods, specific knock out mice, and HSV mutants we will: (1) Determine the role of PML and PML-NB formation in vivo on HSV: (i) lytic infection, (ii) establishment and maintenance of latent infections, and (iii) exit from latency and reactivation; and (2) Determine the biological significance of PML disruption by ICP0 in vivo: (i) during acute ganglion infection; and (ii) in sensory neurons during reactivation from latency. PUBLIC HEALTH RELEVANCE: We propose to determine the viral/host interactions that govern the establishment and maintenance of herpes simplex virus latency and periodic entry into the lytic replicative cycle. This knowledge will lead directly to improved design of vaccines, gene transfer vectors, oncolytic viruses to treat cancer, and may reveal new anti-viral targets.

描述（由申请方提供）：单纯疱疹病毒感染是全球散发性致死性脑炎和美国感染性失明的主要原因。传播给新生儿与高发病率和死亡率有关，生殖器HSV感染的个体获得HIV的可能性高2-3倍。一旦被感染，目前没有办法消除潜伏的病毒基因组，它在宿主的生命中持续存在，并周期性地重新激活，产生感染性病毒后代，然后传播到新的宿主。考虑到目前超过70%的世界人口感染HSV，这种病毒对人类健康的直接和间接影响是深远的。尽管如此重要，我们对HSV体内发病机制核心方面的病毒/宿主相互作用的理解，即潜伏期的建立和再激活，仍然不足以指导预防和治疗策略的合理设计。拟议研究的长期目标是了解HSV和神经系统之间的相互作用，这些相互作用导致潜伏期的建立和随后的再激活以及长期相关的病理。在确定参与调节潜伏期的关键病毒基因方面已经取得了进展，但神经元中破坏或增强进入和退出潜伏期的生理变化尚不清楚。在这项提案中，我们将继续我们的重要新的观察，即早幼粒细胞白血病蛋白（PML）和PML核小体（PML-NB）在体内神经元中的形成在潜伏期和再激活的建立中起着核心作用。使用现有技术的定量体内方法、特异性敲除小鼠和HSV突变体，我们将：（1）确定体内PML和PML-NB形成对HSV的作用：（i）裂解性感染，（ii）潜伏感染的建立和维持，以及（iii）退出潜伏期和再激活;和（2）确定体内ICP 0破坏PML的生物学意义：（i）在急性神经节感染期间;和（ii）在从潜伏期再激活期间的感觉神经元中。公共卫生相关性：我们建议确定病毒/宿主的相互作用，管理建立和维持单纯疱疹病毒潜伏期和定期进入裂解复制周期。这些知识将直接导致疫苗，基因转移载体，溶瘤病毒治疗癌症的改进设计，并可能揭示新的抗病毒靶点。